LISATA THERAPEUTICS, INC.

Lisata Therapeutics, Inc.

Biotechnology • Healthcare • Basking Ridge, NJ, United States • LSTA (NCM)

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

908 842 0100 110 Allen Road, Basking Ridge, NJ 07920, United States

Stock Performance (90 Days)

Data through Dec 30, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Lisata Therapeutics Inc 8NE Stock Analysis and Forecast - Stock Price Divergence & Start Building Capital with Zero Risk - earlytimes.in
earlytimes.in • Jan 1
Lisata Therapeutics stock price target raised to $32 from $20 at Brookline - Investing.com
Investing.com • Jul 15
Lisata Therapeutics (NASDAQ: LSTA) extends runway to Q1 2027 with $19M cash, no debt - Stock Titan
Stock Titan • Nov 6
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement - Yahoo Finance
Yahoo Finance • Oct 8
Lisata Therapeutics to Present at LD Micro Main Event XIX - TMX Newsfile
TMX Newsfile • Oct 13

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has LISATA THERAPEUTICS, INC. had layoffs?
No layoff events have been recorded for LISATA THERAPEUTICS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does LISATA THERAPEUTICS, INC. have?
LISATA THERAPEUTICS, INC. has approximately 26 employees.
What industry is LISATA THERAPEUTICS, INC. in?
LISATA THERAPEUTICS, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is LISATA THERAPEUTICS, INC. a publicly traded company?
Yes, LISATA THERAPEUTICS, INC. is publicly traded under the ticker symbol LSTA on the NCM. The company has a market capitalization of approximately $0.02 billion.
Where is LISATA THERAPEUTICS, INC. headquartered?
LISATA THERAPEUTICS, INC. is headquartered in Basking Ridge, NJ, United States at 110 Allen Road, Basking Ridge, NJ 07920, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.